News and Trends 8 Dec 2016 Meet the Newest ALS Pioneer Company from Switzerland …drug candidates using cost-effective clinical strategies. If everything goes as planned, Chorus will step in in 2018, when the first human study of AL-S’ candidate is projected to begin. The… December 8, 2016 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 31 Mar 2023 Candidate found to inhibit malignant melanoma growth Malignant melanoma is a relatively aggressive type of skin cancer. When detected early, it is usually treatable by surgical resection only, but metastases develop, often spreading to distant areas. Currently,… March 31, 2023 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 18 Oct 2016 This New Biotech wants to Regrow Neurons to cure Parkinson’s Mavalon Therapeutics will develop a drug candidate for Parkinson’s that can stop the disease progression by activating the growth of dying neurons. Mavalon Therapeutics, born today in the UK, will… October 18, 2016 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Best in Biotech 16 Apr 2025 HIV innovation: Six companies developing new treatments in 2025 …technology to target and remove latent viral DNA embedded within the host genome. Its lead candidate, EBT-101, employs an adeno-associated virus (AAV) delivery system to introduce CRISPR-Cas9 along with dual… April 16, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 31 Mar 2023 Ablaze Pharmaceuticals to develop first-in-class therapy for liver cancer in China …has been collaborating with Ablaze on an investigator-initiated trial of a radiopharmaceutical drug candidate targeted on PSMA. I am very glad to learn this novel candidate targeted on GPC3 by… March 31, 2023 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 23 Jan 2017 French Biotech partners with Merck to Fight Tumor Resistance Domain Therapeutics and Merck have partnered up to develop immuno-oncology drug candidates that can boost the performance of checkpoint inhibitors. Domain Therapeutics has entered a collaboration and licensing agreement with… January 23, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Best in Biotech 4 Jun 2024 Ohio’s finest: Eight biotech companies leading the way …which is crucial for normal nervous system function. Convelo’s pipeline includes several small molecule candidates in preclinical development. In March 2024, the biotech discussed two new oral treatment candidates, CVL-1001… June 4, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 19 Jun 2024 MASH candidates make a splash after first drug approval …aim to reverse MASH That’s not all. California-based Akero Therapeutics is also in pursuit of MASH drug success. Its candidate efruxifermin (EFX) has been engineered to mimic fibroblast growth factor… June 19, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 13 Jun 2022 GSK positive on RSV vaccine for older adults …and longer-term protection over multiple seasons following one dose of the RSV older adult vaccine candidate. GSK’s RSV older adult vaccine candidate contains a recombinant subunit prefusion RSV F glycoprotein… June 13, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 21 Dec 2023 The big pharma race against deadly RSV steps up in 2023 …vaccine candidate to the market soon. It submitted an application for regulatory approval as well as a Biologics License Application in July. Its investigational candidate MRNA-1345, consists of a single… December 21, 2023 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 17 May 2023 Six Norwegian companies leading the country’s biotech scene …two candidates focused on treating indications including cancer and respiratory diseases. Its lead drug candidate is bemcentinib, which is being investigated as a therapy against acute myeloid leukemia, non-small cell… May 17, 2023 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 20 Feb 2025 3 promising biotech approaches to treat Hunter syndrome, a rare genetic disorder …are pursuing different methods of tackling the disease, with several candidates in clinical trials that are showing promise. In this article, we explore the three main technology approaches for treating… February 20, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email